90 related articles for article (PubMed ID: 23134860)
1. [The molecular mechanism of haemophilia B caused by the Arg327Ile novel mutation in FIX gene in vitro expression].
Zhou JW; Dai J; Ding QL; Yu TT; Lu YL; Wang XF; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):642-7. PubMed ID: 23134860
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B.
Kao CY; Lin CN; Yang YL; Hamaguchi N; Yang SJ; Shen MC; Kao JT; Lin SW
Thromb Haemost; 2011 Apr; 105(4):616-26. PubMed ID: 21301787
[TBL] [Abstract][Full Text] [Related]
3. An important role for the activation peptide domain in controlling factor IX levels in the blood of haemophilia B mice.
Begbie ME; Mamdani A; Gataiance S; Eltringham-Smith LJ; Bhakta V; Hortelano G; Sheffield WP
Thromb Haemost; 2005 Dec; 94(6):1138-47. PubMed ID: 16411385
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of the factor IX Padua mutation into FIX-Triple improves clotting activity in vitro and in vivo.
Kao CY; Yang SJ; Tao MH; Jeng YM; Yu IS; Lin SW
Thromb Haemost; 2013 Aug; 110(2):244-56. PubMed ID: 23676890
[TBL] [Abstract][Full Text] [Related]
5. FIX-Triple, a gain-of-function factor IX variant, improves haemostasis in mouse models without increased risk of thrombosis.
Kao CY; Lin CN; Yu IS; Tao MH; Wu HL; Shi GY; Yang YL; Kao JT; Lin SW
Thromb Haemost; 2010 Aug; 104(2):355-65. PubMed ID: 20539913
[TBL] [Abstract][Full Text] [Related]
6. [Gene diagnosis of 3 haemophilia B families].
Zhang Y; Yang LH; Lu YL; Ding QL; Wang XF; Liu XE; Zhang L
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):179-82. PubMed ID: 18788618
[TBL] [Abstract][Full Text] [Related]
7. [Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B].
Seita I; Shinozawa K; Otaki M; Fujita S; Suzuki T; Amano K; Inaba H; Fukutake K
Rinsho Byori; 2009 May; 57(5):417-24. PubMed ID: 19522246
[TBL] [Abstract][Full Text] [Related]
8. Apparent synonymous mutation F9 c.87A>G causes secretion failure by in-frame mutation with aberrant splicing.
Odaira K; Tamura S; Suzuki N; Kakihara M; Hattori Y; Tokoro M; Suzuki S; Takagi A; Katsumi A; Hayakawa F; Okamoto S; Suzuki A; Kanematsu T; Matsushita T; Kojima T
Thromb Res; 2019 Jul; 179():95-103. PubMed ID: 31102861
[TBL] [Abstract][Full Text] [Related]
9. Expression and Characterization of Gly-317 Variants of Factor IX Causing Variable Bleeding in Hemophilia B Patients.
Lu Q; Yang L; Manithody C; Wang X; Rezaie AR
Biochemistry; 2015 Jun; 54(24):3814-21. PubMed ID: 26023895
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional exploration of three newly identified coagulation factor IX mutations in Chinese hemophilia B patients.
Wang R; Jiang S; Wang X; Wei D; Xu Q; Wu W
Int J Hematol; 2023 Aug; 118(2):201-209. PubMed ID: 37210691
[TBL] [Abstract][Full Text] [Related]
11. Single synonymous mutation in factor IX alters protein properties and underlies haemophilia B.
Simhadri VL; Hamasaki-Katagiri N; Lin BC; Hunt R; Jha S; Tseng SC; Wu A; Bentley AA; Zichel R; Lu Q; Zhu L; Freedberg DI; Monroe DM; Sauna ZE; Peters R; Komar AA; Kimchi-Sarfaty C
J Med Genet; 2017 May; 54(5):338-345. PubMed ID: 28007939
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of the factor IX epidermal growth factor-like domain mutation Ile66Thr associated with mild hemophilia B.
Knobe KE; Persson KE; Sjörin E; Villoutreix BO; Ljung RC
Pathophysiol Haemost Thromb; 2006; 35(5):370-5. PubMed ID: 17230038
[TBL] [Abstract][Full Text] [Related]
13. The carboxyl-terminal region of factor IX is essential for its secretion.
Kurachi S; Pantazatos DP; Kurachi K
Biochemistry; 1997 Apr; 36(14):4337-44. PubMed ID: 9100030
[TBL] [Abstract][Full Text] [Related]
14. A single base pair deletion in the promoter region of the factor IX gene is associated with haemophilia B.
Hall AJ; Chuansumrit A; Peake IR; Winship PR
Thromb Haemost; 1994 Dec; 72(6):799-803. PubMed ID: 7740444
[TBL] [Abstract][Full Text] [Related]
15. Variability in bleeding phenotype in Amish carriers of haemophilia B with the 31008 C-->T mutation.
Sharathkumar A; Hardesty B; Greist A; Salter J; Kerlin B; Heiman M; Sulkin M; Shapiro A
Haemophilia; 2009 Jan; 15(1):91-100. PubMed ID: 18721150
[TBL] [Abstract][Full Text] [Related]
16. Expression of coagulation factor IX in a haematopoietic cell line.
Rodriguez MH; Enjolras N; Plantier JL; Réa M; Leboeuf M; Uzan G; Bordet JC; Négrier C
Thromb Haemost; 2002 Mar; 87(3):366-73. PubMed ID: 11916066
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanisms of recurrent venous thrombosis in two pedigrees with type I antithrombin deficiency].
Xia Y; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Wang XF; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):848-53. PubMed ID: 22339960
[TBL] [Abstract][Full Text] [Related]
18. Six novel and three recurrent mutations in nine Austrian patients with hemophilia B.
Walter J; Pabinger-Fasching I; Watzke HH
Thromb Haemost; 1994 Jul; 72(1):74-7. PubMed ID: 7974379
[TBL] [Abstract][Full Text] [Related]
19. FIX mutation spectrum in haemophilia B patients from Jordan: identification of three novel mutations.
Awidi A; Alhattab D; Bsoul N; Magablah A; Mefleh R; Dweiri M; Fauori AS
Haemophilia; 2011 Jan; 17(1):162-3. PubMed ID: 20695909
[No Abstract] [Full Text] [Related]
20. [Non-viral gene transfer results in therapeutic factor IX levels in haemophilia B mice].
Schüttrumpf J; Milanov P; Roth S; Seifried E; Tonn T
Hamostaseologie; 2008 Oct; 28 Suppl 1():S92-5. PubMed ID: 18958345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
